Senior insider sale
President, R&D at TAKEDA PHARMACEUTICAL CO LTD — senior position signals high conviction
$1.60M
121.13K shares
What this filing means
PLUMP ANDREW STEWART plans to sell 121.13K shares of TAKEDA PHARMACEUTICAL CO LTD valued at approximately $1.60M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/10/2024ACC: 0001395064-24-000139
DirectorOfficer· President, R&D
Since Mar 2026
121.13K
Shares to sell
$1.60M
Approx. market value
260.08K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Awards - Vested.
Compensation
7/1/2024
260.08KTotal acquired260.08K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2024 | Restricted Stock Unit Awards - Vested. Compensation | 260.08K | — |
| Total | 260.08K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
121.13K
Market value
$1.60M
7/11/2024
Total
Units
121.13K
Value
$1.60M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/11/2024 | 121.13K | $1.60M | NYSE | Planned |
| Total | 121.13K | $1.60M | ||